Exercise-induced menstrual dysfunction.

K Henley; J L Vaitukaitis

doi:10.1146/annurev.me.39.020188.002303

Home/Archive/PubMed

PubMed · 3285785

Exercise-induced menstrual dysfunction.

K Henley·J L Vaitukaitis

View original source ↗Export metadata ↓

Abstract

Menstrual cycle changes associated with vigorous exercise can range widely. They may be only subtle abnormalities, ranging from delayed onset of spontaneous menses or anovulatory cycles to loss of spontaneous menses. They may be more serious, however. Significant adverse bone mineral changes, resulting in clinically significant osteoporosis and fractures, may occur concomitantly with exercise-induced menstrual dysfunction.

Explore related subjects

Amenorrhea Body Composition Bone and Bones Female Humans Menarche Menstrual Cycle Nutritional Status Parity Physical Exertion Stress, Psychological Journal Article Review

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

K Henley, J L Vaitukaitis. 1988. Exercise-induced menstrual dysfunction.. https://doi.org/10.1146/annurev.me.39.020188.002303

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1992

Continuous combined conjugated equine estrogen-progestogen therapy: effects of medroxyprogesterone acetate and norethindrone acetate on bleeding patterns and endometrial histologic diagnosis.

OBJECTIVES: This study was designed to assess the incidence of amenorrhea with continuous combined therapy by using two different progestogens and to determine whether early bleeding predicts subsequent bleeding and endometrial response. STUDY DESIGN: Seventy-nine postmenopausal women on sequential estrogen-progestogen treatment were switched to continuous combined estrogen-progestogen therapy comprising conjugated equine estrogens 0.625 mg daily with either norethindrone acetate 0.35 mg twice daily or medroxyprogesterone acetate 2.5 mg twice daily added continuously for 78 weeks. All bleeding was recorded, and endometrial biopsies were performed at 26 and 78 weeks. RESULTS: Only one third of the women who starting the study had amenorrhea by week 78, but 46 (62%) of these women had withdrawn, mainly because of chronic irregular bleeding. Endometrial atrophy was observed in the majority of biopsy specimens. The two progestogens had similar effects. Bleeding patterns were useful predictors of subsequent bleeding, but not of endometrial response. CONCLUSIONS: Persistent irregular bleeding is common with continuous combined estrogen-progestogen therapy. Women with persistent early bleeding should probably revert to sequential treatment. Regular endometrial sampling is advised.

Amenorrhea↗

PubMed1992

Measurement of post-partum amenorrhoea in Bangladesh.

Reported information on the duration of post-partum amenorrhoea usually shows considerable number preference, particularly at 6-monthly intervals. This paper presents a technique for smoothing such amenorrhoea data using a modified exponential curve. An attempt has also been made to estimate the average number of months a mother is expected to remain amenorrhoeic.

Amenorrhea↗

PubMed1992

Correlation between subsequent lengths of postpartum amenorrhoea in a prospective study of breast-feeding women in rural Bangladesh.

The relationship between subsequent lengths of lactational amenorrhoea for individual women in a prospective study of breast-feeding women in Bangladesh was studied. The data indicate that previous length of amenorrhoea has significant predictive value for the subsequent length of amenorrhoea. Information on previous experience with lactational amenorrhoea should be therefore incorporated into guidelines for the introduction of family planning during lactation.

Amenorrhea↗